Results 271 to 280 of about 166,279 (314)
Some of the next articles are maybe not open access.
Current Opinion in Rheumatology, 2001
Methotrexate and leflunomide are both effective drugs in the treatment of patients with rheumatoid arthritis. Methotrexate has been available for many years, whereas leflunomide is a relatively new drug. Several large trials describing its efficacy and safety in comparison with both sulfasalazine and methotrexate and with placebo have been published ...
Laan, R.F.J.M. +2 more
openaire +3 more sources
Methotrexate and leflunomide are both effective drugs in the treatment of patients with rheumatoid arthritis. Methotrexate has been available for many years, whereas leflunomide is a relatively new drug. Several large trials describing its efficacy and safety in comparison with both sulfasalazine and methotrexate and with placebo have been published ...
Laan, R.F.J.M. +2 more
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1973
The therapy of severe refractory psoriasis with the folic acid antagonist, methotrexate, recently received Food and Drug Administration approval. The folic acid antagonists were first used for psoriasis in 1951, and since then an extensive literature has attested the efficacy of methotrexate for treating various forms of psoriasis and psoriatic ...
openaire +2 more sources
The therapy of severe refractory psoriasis with the folic acid antagonist, methotrexate, recently received Food and Drug Administration approval. The folic acid antagonists were first used for psoriasis in 1951, and since then an extensive literature has attested the efficacy of methotrexate for treating various forms of psoriasis and psoriatic ...
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1969
To the Editor.— The editorial ( 212 : 314, 1970) on psoriasis, methotrexate, and cirrhosis presents a cogent and balanced approach to the treatment of a patient with a long-term and recurrent problem. We feel that one statement ("... indications are expanding to include milder degrees of involvement where only cosmetic inconvenience exists") may be ...
openaire +2 more sources
To the Editor.— The editorial ( 212 : 314, 1970) on psoriasis, methotrexate, and cirrhosis presents a cogent and balanced approach to the treatment of a patient with a long-term and recurrent problem. We feel that one statement ("... indications are expanding to include milder degrees of involvement where only cosmetic inconvenience exists") may be ...
openaire +2 more sources